Empirical Antibiotic Treatment for Typhoid Fever
Azithromycin 500 mg once daily for 7 days is the preferred empirical treatment for adults with suspected typhoid fever, particularly given the widespread fluoroquinolone resistance exceeding 70% in South and Southeast Asia. 1, 2
First-Line Empirical Regimen
- Start azithromycin 500 mg orally once daily for 7 days as the initial empirical therapy for suspected typhoid fever in adults 1, 2, 3
- Azithromycin demonstrates a 52% reduction in clinical failure compared to fluoroquinolones (OR 0.48,95% CI 0.26-0.89) 2, 3
- Hospital stay is shortened by approximately 1 day versus fluoroquinolones (mean difference -1.04 days) 2, 3
- Relapse risk is dramatically lower with azithromycin than ceftriaxone (OR 0.09,95% CI 0.01-0.70) 2, 3
Critical Action Before Starting Therapy
- Obtain blood cultures immediately before initiating antibiotics—blood cultures have the highest diagnostic yield (40-80% sensitivity) within the first week of symptoms 3
- Also collect stool and urine cultures, though these become positive only after the first week 3
- In patients with sepsis features, start broad-spectrum empirical therapy immediately after collecting cultures; do not delay treatment 1
Alternative Regimens When Azithromycin Cannot Be Used
Second-Line: Ceftriaxone
- Ceftriaxone 1-2 g IV/IM once daily for 5-7 days is the recommended alternative when azithromycin is unavailable or contraindicated 2, 3
- All S. Typhi isolates from the UK in 2006 remained 100% susceptible to ceftriaxone despite >70% fluoroquinolone resistance 3
- Ceftriaxone may result in decreased clinical failure compared to azithromycin, though relapse rates may be higher 4
Avoid Cefixime as Empirical Therapy
- Do not use cefixime empirically—treatment failure rates range from 4% to 37.6% 2, 3
- Cefixime carries a 13-fold higher risk of clinical failure compared to fluoroquinolones (RR 13.39,95% CI 3.24-55.39) 3, 4
- If cefixime must be used, a mandatory test-of-cure at 1 week is required 2
Fluoroquinolones: Geographic Restrictions Apply
- Never use ciprofloxacin or ofloxacin empirically for cases from South or Southeast Asia—resistance rates exceed 70% and approach 96% in some regions 1, 2, 3
- In Thailand, 93% of S. Typhi isolates are ciprofloxacin-resistant 2, 3
- Fluoroquinolones may only be considered when culture confirms nalidixic acid susceptibility AND the case is not from South/Southeast Asia 3
Expected Clinical Response and Monitoring
- Fever should resolve within 4-5 days of appropriate therapy 2, 3, 5
- If no clinical improvement occurs by day 5, consider antimicrobial resistance or alternative diagnosis and switch therapy 2, 5
- Complete the full 7-day course even if fever resolves early—premature discontinuation increases relapse risk to 10-15% 2, 3, 5
Critical Pitfalls to Avoid
- Never use cefuroxime (a second-generation cephalosporin)—it has significantly weaker activity against Salmonella species compared to third-generation agents and is not listed in WHO, AAP, or IDSA guidelines 2
- Do not rely on Widal serologic testing—it has inadequate sensitivity and specificity and should not replace culture-based diagnosis 3
- Avoid empiric fluoroquinolones for travelers returning from endemic areas—resistance patterns make them unreliable as first-line therapy 1, 2, 3
When to Switch Therapy
- If ceftriaxone fails to achieve fever clearance within 5 days, switch immediately to azithromycin 5
- Monitor for persistent fever, worsening symptoms, or development of complications as indicators of treatment failure 5
- Obtain repeat blood cultures before switching to guide definitive therapy 5
Complications Requiring Urgent Attention
- Intestinal perforation occurs in 10-15% of patients when illness duration exceeds 2 weeks—surgical intervention is required with an 88% success rate 2, 3
- Other severe complications (gastrointestinal bleeding, typhoid encephalopathy) also affect 10-15% of patients with prolonged untreated illness 3